ValuEngine upgraded shares of NCI Inc (NASDAQ:NCIT) from a hold rating to a buy rating in a report released on Friday morning.

A number of other analysts also recently weighed in on NCIT. Noble Financial restated a buy rating on shares of NCI in a research note on Friday, May 12th. Cowen and Company restated a buy rating and issued a $16.50 price target on shares of NCI in a research note on Monday, April 10th. Zacks Investment Research upgraded NCI from a sell rating to a hold rating in a research note on Saturday, May 13th. Finally, FBR & Co restated a hold rating and issued a $11.00 price target on shares of NCI in a research note on Tuesday, April 4th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of Buy and a consensus price target of $13.75.

NCI (NCIT) traded up 1.03% during midday trading on Friday, reaching $19.70. The company’s stock had a trading volume of 49,136 shares. The stock’s 50 day moving average is $16.41 and its 200 day moving average is $14.43. NCI has a 12-month low of $10.98 and a 12-month high of $19.95. The stock has a market cap of $266.95 million, a P/E ratio of 44.07 and a beta of 1.02.

NCI (NASDAQ:NCIT) last released its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.21 by $0.04. The business had revenue of $78.75 million for the quarter, compared to analyst estimates of $76.55 million. NCI had a return on equity of 12.10% and a net margin of 4.06%. Analysts anticipate that NCI will post $1.01 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “NCI Inc (NCIT) Upgraded to “Buy” by ValuEngine” was first reported by Financial Market News and is the property of of Financial Market News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.financial-market-news.com/2017/06/05/nci-inc-ncit-upgraded-to-buy-by-valuengine.html.

Several hedge funds have recently bought and sold shares of the stock. Russell Investments Group Ltd. acquired a new stake in NCI during the fourth quarter worth $216,000. State Street Corp increased its stake in NCI by 24.8% in the fourth quarter. State Street Corp now owns 64,343 shares of the information technology services provider’s stock worth $898,000 after buying an additional 12,784 shares during the period. Dimensional Fund Advisors LP increased its stake in NCI by 1.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 300,695 shares of the information technology services provider’s stock worth $4,195,000 after buying an additional 5,301 shares during the period. Renaissance Technologies LLC increased its stake in NCI by 2.5% in the fourth quarter. Renaissance Technologies LLC now owns 384,725 shares of the information technology services provider’s stock worth $5,367,000 after buying an additional 9,225 shares during the period. Finally, PagnatoKarp Partners LLC acquired a new stake in NCI during the fourth quarter worth $875,000. Hedge funds and other institutional investors own 34.36% of the company’s stock.

About NCI

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for NCI Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc and related companies with MarketBeat.com's FREE daily email newsletter.